Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ESG | Ann: Dividend component details | 15/07/25 | 0 | 92 | |||
|
|||||||
ESG | Ann: Issued Units Outstanding as at 30 June 2025 | 07/07/25 | 0 | 134 | |||
|
|||||||
ESG | Ann: Dividend Reinvestment Plan Prices | 01/07/25 | 0 | 102 | |||
|
|||||||
ESG | Ann: Final Dividend/Distribution for period ending 30 June 2025 | 30/06/25 | 0 | 111 | |||
|
|||||||
ESG | Ann: Dividend timetable | 24/06/25 | 0 | 211 | |||
|
|||||||
ESG | Ann: Issued Units Outstanding as at 31 May 2025 | 06/06/25 | 0 | 155 | |||
|
|||||||
ESG | Ann: Issued Units Outstanding as at 30 April 2025 - correction | 08/05/25 | 0 | 163 | |||
|
|||||||
ESG | Ann: Issued Units Outstanding as at 30 April 2025 | 07/05/25 | 0 | 156 | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |